Study finds link between prostate cancer therapy and dementia risk

A study out of the University of Pennsylvania’s Perelman School of Medicine has found a link between drugs commonly used to treat prostate cancer and an increased risk of developing dementia. The study looked at more than 150,000 men who had prostate cancer, 62,330 of whom started receiving androgen deprivation therapy (ADT) within two years of being diagnosed. READ: Two …